Table 4 Resilience, health-related quality of life, life satisfaction, anxiety, and depression scores
Variable | Resilience (RS-25) Scale 25–175 | Health-related quality of life (15D) Scale 0.0–1.0 | Life satisfaction (LS-4) Scale 4–20 | Anxiety (HADS) Scale 0–21 | Depression (HADS) Scale 0–21 |
|---|---|---|---|---|---|
Benign disease before surgery (n = 190) | |||||
Mean (SD) | 141.7 (18.8) | 0.902 (0.082) | 8.1 (2.9) | 5.9 (3.2) | 2.8 (2.8) |
Dichotomizeda (n) | 141/44 | NA | 160/24 | 166/17 | 179/4 |
Benign disease at 12 months after surgery (n = 171) | |||||
Mean (SD) | 142.8 (21.9) | 0.920 (0.086) | 7.8 (2.7) | 5.2 (2.8) | 2.9 (2.8) |
Dichotomizeda (n) | 131/40 | NA | 152/19 | 161/10 | 168/3 |
Benign before surgery versus at 12 months: mean difference [95%CI]; p value | − 0.6 [− 3.7, 2.4]; p = 0.67 | − 0.012 [− 0.026, 0.002]; p = 0.09 | 0.2 [− 0.2, 0.6]; p = 0.25 | 0.5 [0.1, 1.0]; p = 0.016 | − 0.1 [− 0.5, 0.2]; p = 0.56 |
Malignant disease before surgery (n = 81) | |||||
Mean (SD) | 141.7 (18.8) | 0.896 (0.085) | 9.1 (3.3) | 7.0 (3.5) | 3.4 (2.7) |
Dichotomizeda (n) | 59/19 | NA | 64/16 | 67/13 | 80/0 |
Benign versus Malignant before surgery: mean difference [95%CI]; p value | 0.041 [− 4.9, 4.9]; p = 0.99 | 0.007 [− 0.021, 0.034]; p = 0.64 | − 1.0 [− 0.2, − 1.8]; p = 0.011 | − 1.2 [− 0.3, − 2.0]; p = 0.008 | − 0.6 [− 1.3, 0.2]; p = 0.12 |
Malignant disease at 12 months after surgery (n = 71) | |||||
Mean (SD) | 143.1 (22.6) | 0.878 (0.099) | 8.2 (3.1) | 5.2 (3.1) | 3.4 (3.4) |
Dichotomizeda (n) | 54/15 | NA | 64/7 | 68/3 | 69/2 |
Malignant before surgery vs. at 12 months: mean difference [95%CI]; p value | − 1.4 [− 5.2, 2.4]; p = 0.46 | 0.016 [− 0.006, 0.038]; p = 0.15 | 0.7 [0.1, 1.4]; p = 0.023 | 1.7 [1.1, 2.4]; p = 0.001 | − 0.1 [− 0.8, 0.6]; p = 0.75 |
Benign vs. Malignant at 12 months: mean difference [95%CI]; p value | − 0.4 [− 6.6, 5.8]; p = 0.91 | 0.042 [0.007, 0.076]; p = 0.02 | − 0.4 [− 1,2, 0.4]; p = 0.34 | 0.01 [− 0.8, 0.8]; p = 0.97 | − 0.6 [− 1.5, 0.3]; p = 0.22 |